Status:

UNKNOWN

Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

Harvard Medical School (HMS and HSDM)

Conditions:

Parkinson's Disease

Eligibility:

All Genders

21+ years

Brief Summary

The Harvard Biomarker Study is a Harvard-wide, longitudinal case-control study designed for discovering, replicating, and developing biomarkers for Parkinson's disease and Alzheimer's disease. High-qu...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Cases with PD:
  • Age ≥ 21
  • UK Parkinson's Disease Society Brain Bank criteria or movement disorder specialist diagnosis of PD
  • Hoehn \& Yahr stage ≤ 3.0
  • Mini Mental State Exam score \>21 OR authorized legal guardian available to sign consent
  • Able to provide informed consent
  • Inclusion Criteria for Controls:
  • Age ≥ 21
  • Absence of any neurological disease
  • No family history of a first-degree relative with PD
  • Mini Mental State Exam score \>21 OR authorized legal guardian available to sign consent
  • Able to provide informed consent
  • Exclusion Criteria for Cases and Controls:
  • Acquired or inherited bleeding disorders
  • Hematologic malignancies
  • Hematocrit \< 30
  • Active ulcer or active colitis
  • Known pregnancy
  • Clinical contraindications to lumbar puncture (including: known mass lesion of the CNS or evidence for raised intracranial pressure on fundoscopic exam; abnormal coagulation tests; platelet count \< 50,000; subject on warfarin (coumadin), heparin, dabigatran, rivaroxiban or apixaban; subject on both aspirin and clopidogrel (Plavix); infection near the LP site or spinal deformity; known allergy to lidocaine)

Exclusion

    Key Trial Info

    Start Date :

    September 1 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2017

    Estimated Enrollment :

    76 Patients enrolled

    Trial Details

    Trial ID

    NCT01867788

    Start Date

    September 1 2012

    End Date

    September 1 2017

    Last Update

    January 12 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Massachusetts General Hospital

    Boston, Massachusetts, United States, 02114